Intech Investment Management LLC Buys Shares of 15,079 Astrana Health, Inc. (NASDAQ:ASTH)

Intech Investment Management LLC purchased a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, HoldingsChannel reports. The institutional investor purchased 15,079 shares of the company’s stock, valued at approximately $874,000.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC bought a new position in Astrana Health during the third quarter worth $34,000. Nisa Investment Advisors LLC acquired a new stake in Astrana Health in the 3rd quarter worth $35,000. KBC Group NV bought a new position in shares of Astrana Health during the 3rd quarter worth about $70,000. Quest Partners LLC acquired a new position in shares of Astrana Health during the third quarter valued at about $133,000. Finally, Central Pacific Bank Trust Division acquired a new position in shares of Astrana Health during the third quarter valued at about $160,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Trading Up 0.9 %

Shares of Astrana Health stock opened at $42.86 on Friday. The stock has a market capitalization of $2.41 billion, a P/E ratio of 32.97, a price-to-earnings-growth ratio of 1.97 and a beta of 1.24. Astrana Health, Inc. has a 12-month low of $32.32 and a 12-month high of $63.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a 50-day simple moving average of $53.37 and a 200 day simple moving average of $47.95.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the previous year, the company posted $0.47 earnings per share. Research analysts expect that Astrana Health, Inc. will post 1.17 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have commented on ASTH. TD Cowen started coverage on Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. BTIG Research raised their target price on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Stifel Nicolaus raised their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Finally, Truist Financial lifted their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $65.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.